top of page


About GlycoMark®
-
An FDA-cleared blood test specific to detecting recent hyperglycemia and hyperglycemic excursions (occurring in the fasting state, postprandial, or both).
-
Reveals recent trends toward or away from A1C goals, suggesting improving or worsening control.
-
Is Independently associated with increased rates of diabetes complications.
-
When used with A1C, provides a more complete assessment of glycemic control to identify patients that may benefit from closer diabetes management.
-
This is a non-coverage policy for the GlycoMark® assay. The assay is not considered reasonable and necessary for the management of diabetes or the prevention of diabetic complications and is NOT COVERED by Medicare.
GlycoMark® Videos
GlycoMark:
A Tale of Two Patients
Pairing A1C With Glycomark
What Clinicians Are Saying
Poor Glycemic Control and the Diabetes Healthcare Burden
GlycoMark:
A Patient's Experience
bottom of page